跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 100,881 条关于
“Oxford Cancer Biomarkers”
全部
100,881
临床试验
81,219
药物
2,300
机构
1,122
资讯
16,240
去年
Oxford Cancer Biomarkers Partners with Mira Precision Health to Advance ToxNav® Test for 5FU/Capecitabine Toxicity Prediction in US Market
去年
Oxford BioDynamics' EpiSwitch Biomarkers Show Promise in Pfizer Bladder Cancer Trial
去年
Oxford and GSK Launch £50 Million Program to Develop Cancer Prevention Vaccine
去年
Molecular Testing Advances Personalized Treatment Strategies in Ovarian Cancer
去年
MyMelanoma Study Joins NHS DigiTrials to Enhance Melanoma Research
2年前
Oxford Scientists Develop First Cancer Prevention Vaccine for Lynch Syndrome Patients
9个月前
Oxford BioTherapeutics Partners with GSK in Multi-Target Cancer Drug Discovery Collaboration
10个月前
Oxford and GSK Launch £50 Million Partnership to Advance Cancer Prevention and Inflammatory Disease Research
7个月前
Oxford Completes Phase 0 Trial of IGF Antibody Xentuzumab in Prostate Cancer Patients
去年
NIAGARA Trial: Durvalumab Plus Chemotherapy Improves Survival in Bladder Cancer
第 1 页,共 1624 页
上一页
下一页